中度主动脉瓣狭窄伴左室舒张功能障碍的预后意义
本研究纳入1247例中度主动脉瓣狭窄且左室射血分数≥50%的患者,按2016年ASE/EACVI指南评估左室舒张功能。43%患者存在左室舒张功能障碍,其1年、3年、5年全因死亡率显著高于舒张功能正常者。左室舒张功能障碍是全因死亡和全因死亡+主动脉瓣置换复合终点的独立预测因素。
要点
- 中度主动脉瓣狭窄患者中43%存在左室舒张功能障碍。
- 左室舒张功能障碍患者1年、3年、5年死亡率分别为13%、30%、41%。
- 左室舒张功能障碍是全因死亡和全因死亡+AVR复合终点的独立预测因素。
核心结论
- 在中度主动脉瓣狭窄且左室收缩功能保留的患者中,左室舒张功能障碍与全因死亡及全因死亡+主动脉瓣置换复合终点独立相关。
研究设计与样本
- 回顾性队列研究,纳入1247例首次诊断中度主动脉瓣狭窄(主动脉瓣面积>1.0且≤1.5 cm2)且左室射血分数≥50%的患者,年龄74±10岁,47%为男性。
主要发现
- 535例(43%)患者基线存在左室舒张功能障碍。
- 左室舒张功能障碍患者1年、3年、5年全因死亡率分别为13%、30%、41%,显著高于舒张功能正常者的6%、17%、29%(p<0.001)。
- 多变量分析显示左室舒张功能障碍与全因死亡独立相关(HR 1.368;95% CI 1.085-1.725;p=0.008)。
- 左室舒张功能障碍与全因死亡+主动脉瓣置换复合终点独立相关(HR 1.241;95% CI 1.035-1.488;p=0.020)。
临床怎么用
- 对中度主动脉瓣狭窄且左室收缩功能保留的患者,应评估左室舒张功能以辅助风险分层。
局限性
- 原文未报告研究设计细节及局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the prognostic impact of left ventricular (LV) diastolic dysfunction in patients with moderate aortic stenosis (AS) and preserved LV systolic function. METHODS: Patients with a first diagnosis of moderate AS (aortic valve area >1.0 and ≤1.5 cm2) and preserved LV systolic function (LV ejection fraction ≥50%) were identified. LV diastolic function was evaluated using echocardiographic criteria according to the 2016 American Society of Echocardiography/European Association of Cardiovascular Imaging guidelines. Clinical outcomes were defined as all-cause mortality and a composite of all-cause mortality and aortic valve replacement (AVR). RESULTS: Of 1247 patients (age 74±10 years, 47% men), 535 (43%) had LV diastolic dysfunction at baseline. Patients with LV diastolic dysfunction showed significantly higher mortality rates at 1-year, 3-year and 5-year follow-up (13%, 30% and 41%, respectively) when compared with patients with normal LV diastolic function (6%, 17% and 29%, respectively) (p<0.001). On multivariable analysis, LV diastolic dysfunction was independently associated with all-cause mortality (HR 1.368; 95% CI 1.085 to 1.725; p=0.008) and the composite endpoint of all-cause mortality and AVR (HR 1.241; 95% CI 1.035 to 1.488; p=0.020). CONCLUSIONS: LV diastolic dysfunction is independently associated with all-cause mortality and the composite endpoint of all-cause mortality and AVR in patients with moderate AS and preserved LV systolic function. Assessment of LV diastolic function therefore contributes significantly to the risk stratification of patients with moderate AS. Future clinical trials are needed to investigate whether patients with moderate AS and LV diastolic dysfunction may benefit from earlier valve intervention.
引用
- Stassen J, Ewe SH, Butcher SC, et al. Prognostic implications of left ventricular diastolic dysfunction in moderate aortic stenosis. Heart. 2022. PMID: 35688475. doi:10.1136/heartjnl-2022-320886
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。